Nicholas Investment Partners’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-428,378
Closed -$14.6M 207
2021
Q4
$14.6M Buy
428,378
+109,751
+34% +$4.3M 0.93% 32
2021
Q3
$15.4M Sell
318,627
-154,637
-33% -$7.16M 1.12% 18
2021
Q2
$21.4M Buy
473,264
+2,812
+0.6% +$125K 1.34% 15
2021
Q1
$22.7M Buy
470,452
+49,645
+12% +$2.58M 1.58% 10
2020
Q4
$22.7M Buy
420,807
+717
+0.2% +$32.4K 1.75% 11
2020
Q3
$15.5M Buy
420,090
+337,725
+410% +$12.6M 1.68% 14
2020
Q2
$2.55M Sell
82,365
-97,205
-54% -$2.69M 0.52% 74
2020
Q1
$4.96M Sell
179,570
-4,906
-3% -$147K 0.97% 27
2019
Q4
$5.4M Sell
184,476
-141,577
-43% -$3.37M 0.56% 48
2019
Q3
$6.23M Buy
326,053
+38,739
+13% +$909K 0.52% 64
2019
Q2
$6.3M Sell
287,314
-1,574
-0.5% -$34.5K 0.58% 53
2019
Q1
$5.91M Sell
288,888
-22,073
-7% -$384K 0.53% 45
2018
Q4
$3.92M Sell
310,961
-1,340
-0.4% -$20K 0.42% 82
2018
Q3
$4.79M Buy
+312,301
New +$4.32M 0.38% 93
2017
Q1
Sell
-229,190
Closed -$1.96M 276
2016
Q4
$1.96M Sell
229,190
-89,296
-28% -$765K 0.15% 231
2016
Q3
$2.62M Hold
318,486
0.17% 219
2016
Q2
$2.56M Buy
318,486
+14,676
+5% +$118K 0.18% 230
2016
Q1
$2.05M Buy
303,810
+94,665
+45% +$623K 0.15% 231
2015
Q4
$1.65M Buy
+209,145
New +$1.53M 0.11% 265
2015
Q3
Sell
-167,338
Closed -$905K 313
2015
Q2
$905K Sell
167,338
-53,623
-24% -$277K 0.06% 292
2015
Q1
$1.03M Buy
220,961
+51,485
+30% +$224K 0.06% 289
2014
Q4
$707K Sell
169,476
-26,097
-13% -$120K 0.04% 293
2014
Q3
$1.02M Buy
+195,573
New +$1M 0.06% 281

Other funds holding NEO

Nicholas Investment Partners's NEO Position: Q1 2022 in Review

Nicholas Investment Partners sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 428,378 shares — an estimated $14.6M sold.

Nicholas Investment Partners first reported a position in NEO in Q3 2014 and held it in 23 quarters. The position peaked at $22.7M in Q1 2021. 280 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Nicholas Investment Partners reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 428,378 NeoGenomics shares in Q1 2022, an estimated $14.6M.
  • Nicholas Investment Partners first reported a position in NeoGenomics in Q3 2014 and held it in 23 quarters.
  • Nicholas Investment Partners's NeoGenomics position peaked at $22.7M in Q1 2021.
  • 280 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Nicholas Investment Partners's 13F filing for Q1 2022, filed 10 May 2022.